Shares of Laurus Labs climbed 6 percent on Thursday after the pharma company received USFDA approval for a generic drug used in the treatment of diabetes.The stock rose 5.84 percent to hit a high of Rs 464.35 on the BSE.For more information on stock tips and quick free trial click here > 911 133 9000
Wednesday, 29 August 2018
LaurusLabs climbs 6% on USFDA approval
23:59
Unknown
No comments
Shares of Laurus Labs climbed 6 percent on Thursday after the pharma company received USFDA approval for a generic drug used in the treatment of diabetes.The stock rose 5.84 percent to hit a high of Rs 464.35 on the BSE.For more information on stock tips and quick free trial click here > 911 133 9000
0 comments:
Post a Comment